Leaflet GRAFALON 20mg / ml concentrate for solution for injection

Product code:
W61725002
Quantity:
10
Indicated for:
immunosuppression
Route of administration:
injectable
Substance:
anti-lymphocyte immunoglobulin (immunoglobulin)
ATC
L04AA04 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Precautions:

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

This medicine is subject to additional monitoring.

Anti-lymphocyte immunoglobulin is an immunological preparation used for the prevention and treatment of acute rejection in organ transplantation, as well as for the treatment of severe autoimmune conditions. It works by binding to T-lymphocytes, suppressing the body's immune response.

The medication is administered intravenously, as directed by a doctor, and requires careful monitoring for adverse effects.

Side effects may include fever, chills, skin rash, leukopenia, or thrombocytopenia. In rare cases, anaphylactic reactions or severe infections may occur.

Anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about GRAFALON 20mg / ml

Substance:
anti-lymphocyte immunoglobulin
Date of latest medicines list:
01-07-2015
Product code:
W61725002
Concentration:
20mg / ml
Pharmaceutical form:
concentrate for solution for injection
Packing volume:
10 ml
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
NEOVII BIOTECH GMBH - GERMANIA
Holder:
NEOVII BIOTECH GMBH - GERMANIA
Number:
7711/2015/02
Shelf life:
2 years

Concentrations available for anti-lymphocyte immunoglobulin

  • 20mg/ml
  • 5mg/ml